NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Perfusion


Return to Library

Free Perfusion Articles


University of Torino reports research in brain cancer



2009 AUG 24 - (NewsRx.com) -- According to recent research published in the journal Radiologia Medica, "This study was undertaken to correlate apparent diffusion coefficient (ADC) and relative regional cerebral blood volume (rrCBV) to histological findings in a large series of patients with primary or secondary brain tumours to evaluate diffusion-weighted (DWI) and perfusionweighted (PWI) imaging in the characterisation of cerebral tumors. Ninety-eight patients with cerebral tumours, 46 of which were primary (seven grade 0-I, nine low-grade gliomas, two gliomatosis cerebri, nine lymphomas and 19 high-grade gliomas) and 52 secondary, underwent conventional magnetic resonance (MR) imaging completed with DWI and dynamic contrast susceptibility PWI."

"Both ADC and rrCBV were calculated on a workstation by using Functool 2 software. Student's t test was used to determine any statistically significant differences in the ADC and rrCBV values. Seventeen of 98 tumours were cystic or necrotic (12/17 hypointense and 5/17 hyperintense on DWI); the ADC value of hyperintense cystic areas was 0.97 +/- 0.23x10(-3) mm(2)/s. The ADC value of solid tumours varied between 0.64 and 3.5x10(-3) mm(2)/s. The rrCBV value was 1.4 (sigma 0.66) in low-grade gliomas; 1.22 (sigma 0.25) in lymphomas; 4.5 (sigma 0.85) in grade III gliomas; 3.18 (sigma 1.26) in grade IV gliomas and 2.53 (sigma 1.6) in metastases. DWI has an important role in the differential diagnosis of cystic cerebral masses but not in tumour characterisation," wrote L. Rizzo and colleagues, University of Torino.

The researchers concluded: "PWI is helpful in differentiating high-from low-grade gliomas and lymphomas from high-grade gliomas.."

Rizzo and colleagues published their study in Radiologia Medica (Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation. Radiologia Medica, 2009;114(4):645-659).

For additional information, contact L. Rizzo, University of Torino Sede San Luigi, Ist Radiol, Orbassano, Italy.

The publisher's contact information for the journal Radiologia Medica is: Springer, 233 Spring St., New York, NY 10013, USA.

Keywords: Italy, Orbassano, Brain Cancer, Brain Carcinoma, Gliomatosis, Hematology, Lymphoma, Magnetic Resonance, Oncology, Perfusion, University of Torino.

This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & Central Nervous System Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login